Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.612NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.612NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.612NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.305NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.305NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.305NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.1.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.1.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.11.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.11.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
GK.1.11.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.32.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.32.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.32.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.8.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.8.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HC.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
B.1.1.512NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.512NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.512NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.349NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.349NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.349NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.265NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.265NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.265NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.401NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.401NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.401NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.362NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.362NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.362NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FW.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HN.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HN.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.1.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used